Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efalizumab Conversion in Renal Transplantation
NCT00777400Phase 2Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Dec 2008
- Primary completion
- Apr 2009
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of efalizumab in kidney transplantation, sponsored by University of California, San Francisco. Planned start Dec 2008; status: withdrawn.
02
Drugs
efalizumab
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00777400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00777400.